ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 208652 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 208652; 2) Community: the network communities that were significantly associated with the response to NSC 208652; 3) Molecule: the relationships between components within communities and NSC 208652; 4) MDR: the compounds that were significantly associated with the NSC 208652.

NSC Compound Enrichment Correlation
NSC 105014 Cladribine 0.000931492155975116 0.37281054
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.000931492155975116 0.44561923
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.000931492155975116 0.6333488
NSC 115928 Benzonitrile, 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-, monoethanesulfonate (9CI) 0.00109467026514912 0.58643301
NSC 134228 .alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) 0.00109467026514912 0.20426024
NSC 287459 Cytarabine AY 0.00109467026514912 0.3718321
NSC 651777 Null 0.00109467026514912 0.45431168
NSC 724037 Null 0.00109467026514912 0.56391803
NSC 726671 Null 0.00109467026514912 0.34425044
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.00119931827492062 0.37480353
Total:117  Current:13    [First] [Prev] [Next] [Last]